System Transmission

Top Signal

100#1 JOB

Activity

2172Ripe

+913 today

System

Livenow

Terminal Asset View

stockNASDAQ

NRIX

$15.04-3.65%

Nurix Therapeutics Inc

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

29Overripe

Live Analysis Active

Company Mission

Nurix Therapeutics Inc creates medicines that break down harmful proteins in the body to fight diseases like cancer. Doctors and patients use these drugs because they offer new treatment options when standard therapies fail. The company makes money by partnering with larger pharmaceutical firms and could earn from future drug sales if approved.

NRI

Industry Context

This company operates in the biotechnology sector, focusing on developing innovative therapies for serious diseases. It competes with other biotech firms by advancing drugs through clinical trials to gain regulatory approval. Success depends on scientific breakthroughs, funding, and partnerships with larger pharmaceutical companies.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

82Matrix

Market Momentum

39.0— Oversold / Recovery

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.9x— Normal Volume

Today's Change

-3.65%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing NRIX across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 02:17 AM UTC

As-of As of 2026-03-16T02:02:36.618Z UTC (~15m delay).

Develops drugs that degrade harmful proteins to treat cancers and autoimmune diseases, generating revenue through partnerships and clinical trial milestones.

No technical data available, but watch for price action near $15 as a key psychological level, indicating potential support or resistance.

No volume data available, but monitor if volume spikes above average levels, suggesting institutional interest or news-driven moves.

No industry data available, but watch for sector recovery in biotech, as broader market trends could influence performance.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...